Involving Bacterium, Fungus, Parasite Or Protozoan (e.g., Detecting Pathogen Virulence Factors, Adhesions, Toxins, Etc.) Patents (Class 435/6.15)
  • Patent number: 12262720
    Abstract: Provided herein are fermentation methods that improve the nutritional value and physical properties of microbial oil. Specifically, provided is a method of producing oil with increased omega-7 fatty acids. The method comprises culturing oil-producing microorganisms in a fermentation medium with less than 0.3 mg/L zinc, wherein the culturing produces an oil comprising fatty acids, wherein the oil comprises increased omega-7 fatty acids compared to a control oil. Optionally, the oil is isolated from the microorganisms of the culture.
    Type: Grant
    Filed: November 1, 2019
    Date of Patent: April 1, 2025
    Assignee: Mara Renewables Corporation
    Inventors: Michael Milway, Laura Purdue, Zachary Sun, Mercia Valentine, Joshua Lowrey, Roberto E. Armenta
  • Patent number: 12258614
    Abstract: The invention provides an antibody-based bioanalytical method, specifically a hybridization Chain Reaction-based Method for Amplifying Immunosignals named immunosignal HCR (isHCR), which combines antibody-antigen interactions with hybridization Chain Reaction (HCR) technology for amplifying immunosignals. The invention also provides a kit for performing the above isHCR.
    Type: Grant
    Filed: January 26, 2018
    Date of Patent: March 25, 2025
    Assignee: GenAns Biotechnology Co., Ltd.
    Inventors: Rui Lin, Minmin Luo
  • Patent number: 12258639
    Abstract: Methods and reagents are used to determine the presence of human fecal contamination. These relate to detection of human crAssphage, a bacteriophage present in Bacteroides.
    Type: Grant
    Filed: March 15, 2021
    Date of Patent: March 25, 2025
    Assignees: GOVERNMENT OF THE UNITED STATES AS REPRESENTED BY THE ADMINISTRATOR OF THE U.S. ENVIRONMENTAL PROTECTION AGENCY, University of Pittsburgh—Of the Commonwealth System of Higher Education
    Inventors: Orin C. Shanks, Kyle J. Bibby, Elyse Stachler
  • Patent number: 12216331
    Abstract: Apparatuses, systems, method, reagents, and kits for conducting assays as well as process for their preparation are described. They are particularly well suited for conducting automated analysis in a multi-well plate assay format.
    Type: Grant
    Filed: March 6, 2024
    Date of Patent: February 4, 2025
    Assignee: MESO SCALE TECHNOLOGIES, LLC.
    Inventors: Ian D. Chamberlin, Charles M. Clinton, Eli N. Glezer, Bandele Jeffrey-Coker, Manish Kochar, Sandor Kovacs, D. T. Le, Aaron Leimkuehler, George Sigal, Leo Tabakin, Jon Willoughby
  • Patent number: 12216033
    Abstract: The present disclosure relates to a gel-phase patch that performs a function of assisting in staining during a staining process such as a process of coming into contact with a specimen such as blood to perform a staining function of staining the specimen, a process of fixing the specimen, or a process of forming an optimal pH at a specimen stained by a staining sample. According to an aspect of the present disclosure, a contact-type staining patch includes a staining solution that reacts with a specimen and a gel receptor provided as a gel matrix of a mesh structure in which a pore that accommodates the staining solution is formed and the mesh structure prevents the staining solution in the pore from leaking or degenerating, and having a contact surface that comes into contact with the specimen to transfer some of the staining solution to the specimen.
    Type: Grant
    Filed: July 13, 2023
    Date of Patent: February 4, 2025
    Assignee: NOUL CO, LTD.
    Inventors: Dongyoung Lee, Kyunghwan Kim, Youngmin Shin, Hyunjeong Yang, Chanyang Lim
  • Patent number: 12209239
    Abstract: The disclosure generally relates to compositions and methods for the production of nucleic acid molecules. In some aspects, the invention allows for the microscale generation of nucleic acid molecules, optionally followed by assembly of these nucleic acid molecules into larger molecules. In some aspects, the invention allows for efficient production of nucleic acid molecules (e.g., large nucleic acid molecules such as genomes).
    Type: Grant
    Filed: May 14, 2021
    Date of Patent: January 28, 2025
    Assignees: LIFE TECHNOLOGIES CORPORATION, THERMO FISHER SCIENTIFIC GENEART GMBH
    Inventors: Todd Peterson, Axel Trefzer, Thomas Poehmerer
  • Patent number: 12186382
    Abstract: A vaccine comprising a polypeptide comprising an amino acid sequence of at least 9 contiguous amino acids from the N-terminal region of MAP P900, or a polynucleotide encoding said polypeptide, for use in a method of treating or preventing MAP infection or a condition or symptom associated with MAP infection in a subject.
    Type: Grant
    Filed: July 10, 2019
    Date of Patent: January 7, 2025
    Assignee: HAV VACCINES LIMITED
    Inventor: John Hermon-Taylor
  • Patent number: 12181390
    Abstract: The present disclosure relates to a tissue diagnosis device including a plate supporter configured to support a plate on which a reaction region is placed and a sample is placed in the reaction region, a patch controller configured to support the patch which contains a labeling substance that specifically labels the target substance, and control a position of the patch relative to the reaction region so that the patch provides the labeling substance to the reaction region, and a target substance detector configured to detect the labeling substance and detect the target substance included in the tissue sample.
    Type: Grant
    Filed: August 2, 2023
    Date of Patent: December 31, 2024
    Assignee: NOUL CO., LTD.
    Inventors: Dong Young Lee, Chan Yang Lim, Kyung Hwan Kim
  • Patent number: 12181401
    Abstract: One variation of a method includes, during execution of a tracer test: triggering release of a tracer load into air in an aerosol zone by a dispenser transiently arranged in the aerosol zone, the tracer load including a concentration of aerosol tracers; and recording a timeseries of aerosol data via a sensor unit transiently arranged in the aerosol zone, the timeseries of aerosol data representing concentrations of aerosol particles present in air. The method further includes: based on the timeseries of aerosol data and the concentration, deriving a tracer concentration curve representing change in concentration of aerosol tracer particles; based on characteristics of the tracer concentration curve, deriving an airflow value representing removal of aerosol particles from the aerosol zone during the tracer test; and interpreting an outcome for the tracer test based on a difference between the airflow value and a target airflow value defined for the aerosol zone.
    Type: Grant
    Filed: September 11, 2023
    Date of Patent: December 31, 2024
    Assignee: Poppy Health, Inc.
    Inventors: Kalyan Kottapalli, Sam Molyneux, Konrad Swic, Elizabeth Caley, Aaron Botham
  • Patent number: 12153057
    Abstract: A method for antibiotic therapy guidance, stratification and/or control in a patient with one or more comorbidities comprising an impaired innate immune response and suspected of having an infection. Also, a method for antibiotic therapy guidance, stratification and/or control in a patient with one or more comorbidities comprising an impaired innate immune response, wherein the comorbidity is preferably selected from the group comprising metabolic disorder (obesity), diabetes, hypertension, renal disease, thrombosis, malignancy or cancer, and suspected of having an infection. In particular, the method comprises providing a sample from said patient and determining a level of PCT or fragment(s) thereof in said sample, wherein the level of PCT or fragment(s) thereof in said sample is indicative of whether an initiation or a change of an antibiotic treatment is required. Furthermore, a kit for carrying out the method of the present invention.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: November 26, 2024
    Assignee: B.R.A.H.M.S GMBH
    Inventors: Darius Wilson, Stefan Kirsch
  • Patent number: 12146167
    Abstract: An enzymatically catalyzed method for producing L-glufosinate or a phosphoester of L-glufosinate can be performed. An activated L-homoserine HA is reacted with a substrate S selected from methylphosphinic acid and the esters of methylphosphinic acid. The method makes accessible new substrates in the enzymatic production of L-glufosinate and its phosphoesters.
    Type: Grant
    Filed: March 28, 2022
    Date of Patent: November 19, 2024
    Assignee: Evonik Operations GmbH
    Inventors: Markus Pötter, Ludger Lautenschütz, Daniel Fischer, Jakob Müller
  • Patent number: 12139769
    Abstract: A method of diagnosing bacterial vaginosis in a woman, which involves determining an amount of each of more than one BV-associated bacterium in a vaginal sample obtained from the female and assessing a BV status of the female based on the amount of each of the more than one BV-associated bacterium in the sample.
    Type: Grant
    Filed: July 19, 2022
    Date of Patent: November 12, 2024
    Assignee: Laboratory Corporation of America Holdings
    Inventors: Charles Paul Cartwright, Bryndon Denae Lembke, Kalpana Ramachandran
  • Patent number: 12110544
    Abstract: In a method for extracting microbial DNA from milk, the extracted DNA can be directly used for PCR amplification. The method includes the following steps: treating milk with TE solution, fully disrupting microbial cells by bead milling, immobilizing proteins in the middle layer between the aqueous and organic phases with high-vacuum silicone grease so as to prevent impurities in the middle layer from entering the aqueous phase, etc. The extracted DNA has a high degree of intactness, high concentration and purity.
    Type: Grant
    Filed: July 13, 2018
    Date of Patent: October 8, 2024
    Assignee: INSTITUTE OF ANIMAL SCIENCES, CHINESE ACADEMY OF AGRICULTURAL SCIENCES
    Inventors: Jiaqi Wang, Shengguo Zhao, Nan Zheng, Xu Zhou, Songli Li
  • Patent number: 12110534
    Abstract: The invention is a novel method of sequencing nucleic acids involving making and sequencing a library of single stranded circular target nucleic acids.
    Type: Grant
    Filed: July 31, 2020
    Date of Patent: October 8, 2024
    Assignees: Roche Sequencing Solutions, Inc., Kapa Biosystems, Inc.
    Inventors: Daleen Badenhorst, Michael S. Berry, Richard Dannebaum, Ashley Hayes, Severine Margeridon, Martin Ranik, Etienne Slabbert
  • Patent number: 12070725
    Abstract: A vacuum manifold for filtration microscopy includes a manifold top having multiple openings, and a capture membrane positioned above and spaced apart from the manifold top, where the capture membrane is configured to deflect into contact with a surface of the manifold top when a negative pressure is applied to the multiple openings. A method for filtration microscopy includes the steps of providing a vacuum manifold including a manifold top having a plurality of openings, and a capture membrane positioned above and spaced apart from the manifold top; applying sample drops to sample spots on the membrane, the sample spots positioned above the plurality of openings; applying a negative pressure to the openings such that the capture membrane contacts a surface of the manifold top; and optically imaging particulates on the capture membrane.
    Type: Grant
    Filed: May 11, 2023
    Date of Patent: August 27, 2024
    Assignee: Optofluidics Inc.
    Inventors: Thomas Castner, Robert Hart, Colby Ashcroft, Brian DiPaolo, Nathan Wall
  • Patent number: 12065693
    Abstract: The present invention provides compositions, kits and methods for the selective hybridization and capture of a specific target nucleic acid. The specific target nucleic acid may be present in a heterogeneous mixture of nucleic acids. Selective hybridization and capture provides a target nucleic acid that is substantially free of non-target and/or contaminating nucleic acids. Target nucleic acids that have been selectively hybridized and captured using the current invention are then used in subsequent analysis, wherein the presence of non-target and/or contaminating nucleic acids that interfere with said subsequent analysis have been substantially reduced or eliminated, thereby providing improved analysis results.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: August 20, 2024
    Assignee: Gen-Probe Incorporated
    Inventors: Michael M. Becker, Kristin W. Livezey, Wai-Chung Lam
  • Patent number: 12065652
    Abstract: The present invention is directed to a nucleic acid construct comprising a polynucleotide operably linked to one or more control sequence that directs the expression of the polynucleotide in a host cell, wherein at least one control sequence comprises a promoter sequence of an operon comprising a secA gene or a functional fragment or functional variant thereof and wherein said promoter sequence is heterologous to the polynucleotide. In a further embodiment, the invention is directed to an expression vector and a host cell comprising the nucleic acid construct comprising the promoter sequence described herein and a method of expressing a polynucleotide in a host cell.
    Type: Grant
    Filed: July 11, 2018
    Date of Patent: August 20, 2024
    Assignee: BASF SE
    Inventors: Max Fabian Felle, Bogdan Tokovenko
  • Patent number: 12065690
    Abstract: The invention provides methods, compositions, kits and devices for the detection of target molecules. In some embodiments, the invention allows for multiplexed target molecule detection.
    Type: Grant
    Filed: October 15, 2020
    Date of Patent: August 20, 2024
    Assignee: ROCHE SEQUENCING SOLUTIONS, INC.
    Inventor: Garry P. Nolan
  • Patent number: 12018326
    Abstract: The invention relates to mutant forms of CsgG. The invention also relates to analyte detection and characterization using CsgG.
    Type: Grant
    Filed: October 26, 2021
    Date of Patent: June 25, 2024
    Assignee: Oxford Nanopore Technologies PLC
    Inventors: Lakmal Jayasinghe, Elizabeth Jayne Wallace
  • Patent number: 12018335
    Abstract: Provided are a set of primer pair and probe, having the oligonucleotide sequences as shown in SEQ ID NO: 1, SEQ ID NO: 2 and SEQ ID NO: 3, and a set of primer pair and probe of reference sequence, having the oligonucleotide sequences as shown in SEQ ID NO: 4, SEQ ID NO: 5 and SEQ ID NO: 6. Further provided is the use of the set of primer pair and probe for detecting the common deleted region “chr9:21970277-21985225,hg19”, of CDKN2A in the preparation of a kit for quantitatively detecting the deletion of a human CDKN2A gene copy in a DNA sample to be tested. The new method and the specific primer pair and probe can simply, conveniently and specifically detect the deletion of the CDKN2A gene copy in the sample, and have higher sensitivity than conventional detection methods for copy deletion.
    Type: Grant
    Filed: May 16, 2019
    Date of Patent: June 25, 2024
    Assignee: BEIJING INSTITUTE FOR CANCER RESEARCH
    Inventors: Dajun Deng, Yuan Tian, Jing Zhou, Zhaojun Liu
  • Patent number: 12008747
    Abstract: Embodiments discussed herein facilitate determination of one of a probability of prostate cancer recurrence-free survival or a risk factor associated with prostate cancer based on intra-tumor stromal morphology. Example embodiments can perform operations comprising: accessing a digitized histological image of a prostate of a patient, wherein the histological image comprises a region of interest associated with prostate cancer; identifying nuclei of intra-tumoral stromal cells within the region of interest; extracting, for the region of interest of the digitized histological image, one or more features describing the structure of the intra-tumoral stromal cells; and generating, via a model based at least on the one or more features, one of a probability of prostate cancer recurrence-free survival or a risk score associated with prostate cancer for the patient based at least on the extracted one or more features.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: June 11, 2024
    Assignee: Case Western Reserve University
    Inventors: Anant Madabhushi, Hersh Bhargava, Patrick Leo, Priti Lal
  • Patent number: 12006342
    Abstract: Disclosed are immunogenic proteins from Pseudomonas aeruginosa as well as nucleic acids, vectors and transformed cells useful for expression of the proteins. Also disclosed are methods for prophylaxis of infection with Pseudomonas aeruginosa using the proteins, nucleic acids, vectors or transformed cells.
    Type: Grant
    Filed: November 22, 2021
    Date of Patent: June 11, 2024
    Assignee: Evaxion Biotech A/S
    Inventors: Niels Iversen Møller, Andreas Holm Mattsson
  • Patent number: 11993812
    Abstract: Embodiments of the invention include methods of identifying microorganisms and/or diagnosing infections in subjects cause by microorganisms. Embodiments of the invention may also include further characterizing (e.g., determining the presence of one or more antibiotic resistance markers) the microorganisms and determining a strain identity of the microorganisms.
    Type: Grant
    Filed: August 5, 2021
    Date of Patent: May 28, 2024
    Assignees: The Translational Genomics Research Institute, Arizona Board of Regents acting for and on behalf of Northern Arizona University
    Inventors: Elizabeth Driebe, Jolene Bowers, David Engelthaler, Paul Keim
  • Patent number: 11976193
    Abstract: A method for detecting a thickness of bonded rubber of a carbon black in a natural rubber based for reinforcement performance is provided. An ultra-thin frozen microtome to prepare a sample, a tapping mode of the atomic force microscope is used, and when characterizes the carbon black and rubber composite material, the difference of imaging characteristics between morphological and phase diagrams is used, the characteristics of bonded rubber of carbon black reinforced composite material can be observed to obtain the thickness of bonded rubber, and then influence of bonded rubber on rubber performance and the reinforcement performance of the carbon black in the rubber are analyzed. The method has advantages of simple operation, no need for excessive sample processing, high detection efficiency, clear detection images and high detection accuracy, thereby having better applicability and providing a new method and idea for studying reinforcements of fillers.
    Type: Grant
    Filed: August 11, 2021
    Date of Patent: May 7, 2024
    Assignee: SICHUAN UNIVERSITY OF SCIENCE & ENGINEERING
    Inventors: Jian Chen, Zhiqiang Lei, Long Qing, Rui Li, Sha Liu, Lin Li
  • Patent number: 11961594
    Abstract: A method for identifying two or more infections as related or non-related infections based on an estimated genetic relatedness of the two or more infections, comprising: (i) receiving, for each of two or more infected patients, infection-relevant information comprising an antibiotic resistance profile for the patient's infection, a geo-temporal record for the patient, and a caregiver history for the patient; (ii) estimating, using a trained genetic relatedness model, a genetic relatedness of at least two of the two or more infections; (iii) comparing the estimated genetic relatedness between at least two of the two or more infections to a predetermined threshold; (iv) identifying, based on the comparison, the at least two of the two or more infections as a related infection or a non-related infection.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: April 16, 2024
    Assignee: KONINKLIJKE PHILIPS N.V.
    Inventors: Liyi Xu, Raivo Kolde, Andrew G. Hoss
  • Patent number: 11959838
    Abstract: The disclosure generally relates to the preparation of representative samples from clinical samples, e.g., tumors (whole or in part), lymph nodes, metastases, cysts, polyps, or a combination or portion thereof, using mechanical and/or biochemical dissociation methods to homogenize intact samples or large portions thereof. The resulting homogenate provides the ability to obtain a correct representative sample despite spatial heterogeneity within the sample, increasing detection likelihood of low prevalence subclones, and is suitable for use in various diagnostic assays as well as the production of therapeutics, especially “personalized” anti-tumor vaccines or immune cell based therapies.
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: April 16, 2024
    Assignee: Ventana Medical Systems, Inc.
    Inventors: Nelson Alexander, Aoune Barhoumi, Melinda Day, Lisa Gallegos, Katherine Leith, Samantha Rajkovich, Esteban Roberts, Stacey Stanislaw, Eric Walk
  • Patent number: 11935657
    Abstract: A system and method are provided for collection and testing of a biologic sample. The system and method comprise collecting by a user of a testing device a biologic sample for use with the testing device, assigning correlative values as test results, and receiving the test results at a server disposed on a network. Some aspects further include presenting advertisements and other messages to users through a mobile application operating on a mobile device. These aspects take into account the results of the self-diagnostic test and present different advertisements to the user based on the results of the test.
    Type: Grant
    Filed: August 23, 2021
    Date of Patent: March 19, 2024
    Assignee: Reliant Immune Diagnostics, Inc.
    Inventors: Jovan Hutton Pulitzer, Henry Joseph Legere, III
  • Patent number: 11921113
    Abstract: The present invention provides for excitable molecules positioned near metallic structures, wherein the metallic structures have a particles size from about 1 nm to 1000 nm and wherein the excitable molecules have fluorescence, phosphorescence or alpha-fluorescence emissions that are altered due to positioning near the metal structures. The emission spectra are distorted on either the blue or red edges in a range from 1 to 10 nm thereby changing the color of emissions. Further, the width of the emission spectrum is modified either by narrowing or broadening depending on the material of the metallic structures and type of excitable molecule.
    Type: Grant
    Filed: July 16, 2019
    Date of Patent: March 5, 2024
    Assignee: UNIVERSITY OF MARYLAND, BALTIMORE COUNTY
    Inventor: Chris D. Geddes
  • Patent number: 11896626
    Abstract: Provided herein are multi-strain population control systems, methods, kits, and compositions. Also provided are methods, systems, kits, and compositions for culturing bacterial cells in multi-strain ecosystems, and temporally arranged multi-strain ecosystems or cultures using a synchronized lysis circuit in combination with multiple toxin/antitoxin systems to cycle continuously over a long period of time.
    Type: Grant
    Filed: June 7, 2019
    Date of Patent: February 13, 2024
    Assignee: The Regents of the University of California
    Inventors: Jeff Hasty, Michael Julius Liao, Muhammad Omar Din
  • Patent number: 11884982
    Abstract: The present invention relates to the technical field of biology. Disclosed are a tumor marker, a methylation detection reagent, a kit and application thereof. Disclosed in the present invention is that: a colorectal cancer specimen can be distinguished from a fecal specimen of a normal person by detection a methylation level of COL4A1 gene promoter region. The present invention relates to detecting colorectal cancer by using the methylation detection reagent of the gene.
    Type: Grant
    Filed: May 5, 2019
    Date of Patent: January 30, 2024
    Assignee: CREATIVE BIOSCIENCES (GUANGZHOU) CO.
    Inventors: Xianglin Liu, Rongsong Zhao, Hongzhi Zou
  • Patent number: 11884750
    Abstract: A cell penetrating peptide (CPP) according to the present invention is a novel cationic cell penetrating peptide that can effectively transport a biologically active molecule by passing through a cell membrane even when a biologically active molecule is bound thereto, and compared with conventional CPPs, it has excellent cell permeability enabling the transport of a biologically active molecule into cells, and the delivered biologically active molecule may effectively maintain its activity in cells. Accordingly, the CPP of the present invention may be very useful in various fields including cosmetics, diagnostics, drug delivery systems, recombinant protein vaccines, DNA/RNA therapeutics, and gene and protein therapy.
    Type: Grant
    Filed: July 22, 2022
    Date of Patent: January 30, 2024
    Assignee: CELLTROY CO., LTD.
    Inventors: Chang-Kyu Oh, Jae-Ho Lee, Soon-Ik Park, Jeong-Ho Park, Won-Jin Park, Yun-Chu Cho
  • Patent number: 11884986
    Abstract: The present disclosure provides a transgenic corn comprising event MON87403 that exhibits increased grain yield. The disclosure also provides cells, plant parts, seeds, plants, commodity products related to the event, and DNA molecules that are unique to the event and were created by the insertion of transgenic DNA into the genome of a corn plant. The disclosure further provides methods for detecting the presence of said corn event nucleotide sequences in a sample, probes and primers for use in detecting nucleotide sequences that are diagnostic for the presence of said corn event.
    Type: Grant
    Filed: August 15, 2022
    Date of Patent: January 30, 2024
    Assignee: Monsanto Technology LLC
    Inventors: Thomas R. Adams, John A. Korte, Anagha M. Sant, J. Philip Taylor
  • Patent number: 11866769
    Abstract: Subject of the present invention is a combination of nucleic acid molecules capable of hybridizing with a target nucleic acid sequence. In order to overcome problems with the reproducibility of FISH assays and to decrease assay time, hairpin probes are used in combination with helper probes annealing adjacent to the target site of the hairpin probe.
    Type: Grant
    Filed: January 9, 2014
    Date of Patent: January 9, 2024
    Assignee: MIACOM DIAGNOSTICS GMBH
    Inventors: Ian Peter Thrippleton, Walter Freiherr Von Stein
  • Patent number: 11854384
    Abstract: Systems, devices, and methods are disclosed in which one or more light sources, a detector, a processor and a controller are configured such that light from the one or more light sources improves the ability of a human or automated motor vehicle driver to identify and avoid pedestrians. The one or more light sources may provide spot illumination to moving objects or pedestrians on a road surface, with the spot illumination following the moving object or pedestrians along the portion of the road surface. The one or more light sources may project images on the ground or on other surfaces. The light source may be carried by a pedestrian or on personal transport used by a pedestrian. The light sources may be stationary and provide lighting for a pedestrian street crossing.
    Type: Grant
    Filed: December 19, 2022
    Date of Patent: December 26, 2023
    Assignee: Lumileds LLC
    Inventors: Michael Camras, Jyoti Kiron Bhardwaj
  • Patent number: 11851705
    Abstract: Provided is a method for a two-step multiplex DNA amplification reaction which allows bacterial or fungal DNA analysis without first extracting DNA from the sample, nor without need to enrich microbes by laboratory culture prior to analysis. Without additional DNA purification or analysis, the PCR amplified DNA is administered directly to a microarray designed to interrogate a large panel of meaningful bacteria or fungi as a single multiplex test. Microarray analysis is then performed at ambient temperature, thus enabling substantial simplification of the testing process. It is contemplated that analysis may be conducted on unprocessed and processed leaf wash and similar surface sampling of plant material, cannabis, vegetables, fruit, nuts, spices, grains, other agriculture samples, food samples, or water samples, so as to detect bacterial, yeast, mold or viral, plant or human pathogen contamination.
    Type: Grant
    Filed: March 16, 2020
    Date of Patent: December 26, 2023
    Assignee: PathogenDX Inc
    Inventors: Michael Edward Hogan, Melissa Rose May, Frederick Henry Eggers
  • Patent number: 11834695
    Abstract: The present invention relates to a method for simply diagnosing the progress of disease condition of a Parkinson's disease patient. Provided are a method for determining Parkinson's disease using the number of one or more intestinal bacteria selected from the group consisting of Bifidobacterium, Bacteroides fragilis group, Lactobacillus brevis, and Lactobacillus plantarum subgroup and/or the total number of intestinal bacteria as a marker, and a method for determining Parkinson's disease using the blood LPS level and/or the blood LBP level of a Parkinson's disease patient as an indicator.
    Type: Grant
    Filed: May 17, 2018
    Date of Patent: December 5, 2023
    Assignees: KABUSHIKI KAISHA YAKULT HONSHA, NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY
    Inventors: Hirokazu Tsuji, Takashi Asahara, Koji Nomoto, Masaaki Hirayama, Kinji Ohno
  • Patent number: 11827674
    Abstract: Peptides that form adhesive bonds, even in aqueous and/or saline environments, are disclosed. When aggregated, the peptides may be used in methods for producing hydrogels and/or adhesive materials. Synthetic peptide analogs are provided that are designed based on protein sequences found in barnacle adhesive, and may optionally be augmented with chemistry from other organisms that secrete proteins that adhere to substrates. The peptides may be used, for example, in biomedical and aqueous applications. Methods of using the aggregated peptides as adhesives are also provided.
    Type: Grant
    Filed: February 22, 2023
    Date of Patent: November 28, 2023
    Assignee: The Government of the United States of America, as represented by the Secretary of the Navy
    Inventors: Christopher R. So, Kathryn J. Wahl
  • Patent number: 11821023
    Abstract: The invention relates to methods for capturing a polynucleotide comprising a DNA target segment from a population of polynucleotide molecules using a rotation of a magnetic field to move streptavidin-labeled magnetic beads relative to a buffered liquid medium to increase the probability of capturing and preventing damage to a long polynucleotide comprising a DNA target segment. The methods may use a rotation of the magnetic field relative to the mixture or a rotation of the mixture relative to the magnetic field for causing magnetic bead rotation in the buffered liquid medium and increasing the binding of biotinylated nucleotides of an extended polynucleotide primer to streptavidin-labeled magnetic beads, and winding or condensation of a polynucleotide onto the streptavidin-labeled magnetic beads to prevent damage to the long polynucleotide comprising a DNA target segment.
    Type: Grant
    Filed: May 29, 2019
    Date of Patent: November 21, 2023
    Assignee: GENERATION BIOTECH, LLC
    Inventors: Johannes Dapprich, Karl P. Dresdner, Jr., Richard R. McKay
  • Patent number: 11806392
    Abstract: The present embodiments provide compositions and methods related to novel recombinant protein immunogens, comprising specific portions of alpha helical domains (aHD) and proline rich regions (PRD) of pneumococcal surface protein A (PspA), which portions are linked to provide aHD-PRD constructs. The aHD and PRD proteins constituting the aHD-PRD constructs are selected to maximize cross-reactivity and provide protection against a broad spectrum of pneumococcal serotypes. Immunogenic compositions, including vaccines, comprising at least one aHD PRD construct may also include a non-linked aHD portion. Also provided are recombinant nucleic acid molecules that encode aHD-PRD constructs, vectors and recombinant host cells containing such molecules, aHD-PRD expression products, use of such nucleic acid molecules to express aHD-PRD constructs by recombinant techniques, and use of the expression products to elicit an immune or protective response against pneumococcal disease in a suitable host.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: November 7, 2023
    Assignees: The UAB Research Foundation, The University of Tokyo
    Inventors: David E. Briles, Hiroshi Kiyono, Robert Kneller, Reshmi Mukerji, Kristopher Genschmer, Yoshikazu Yuki
  • Patent number: 11798406
    Abstract: Systems, devices, and methods are disclosed in which one or more light sources, a detector, a processor and a controller are configured such that light from the one or more light sources improves the ability of a human or automated motor vehicle driver to identify and avoid pedestrians. The one or more light sources may provide spot illumination to moving objects or pedestrians on a road surface, with the spot illumination following the moving object or pedestrians along the portion of the road surface. The one or more light sources may project images on the ground or on other surfaces. The light source may be carried by a pedestrian or on personal transport used by a pedestrian. The light sources may be stationary and provide lighting for a pedestrian street crossing.
    Type: Grant
    Filed: December 19, 2022
    Date of Patent: October 24, 2023
    Assignee: Lumileds LLC
    Inventors: Michael Camras, Jyoti Kiron Bhardwaj
  • Patent number: 11725173
    Abstract: The present invention provides an organoid culture device, comprising at least one first chamber for storing a culture medium; at least one second chamber for culturing an organoid; and a channel that interconnects adjacent chambers.
    Type: Grant
    Filed: June 21, 2019
    Date of Patent: August 15, 2023
    Assignee: CELLARTGEN INC.
    Inventors: Seung Woo Cho, Jin Kim, Yoonhee Jin, Ann Na Cho
  • Patent number: 11718881
    Abstract: Provided are a detection kit and detection method for ITGA4 gene methylation. A primer and a probe provided by the present invention are matched, then detection can be carried out by taking a feces sample as an object, and thus the detection is simple, convenient and rapid. The detection can also be carried out on tissue specimens. Moreover, in the process of detecting the samples, the detection specificity and sensitivity are also improved. The experiment proves that for the feces specimen, when the specificity is 95.2%, the sensitivities of the methylated ITGA4 to intestinal cancer and adenoid tumor are 83.8% and 41.6%, respectively; and for the intestinal cancer tissue, when the specificity is 97.6% (40/41), the detection rates for colorectal cancer and adenoid tumor are 96.2% (101/105) and 71.6% (78/109), respectively. The effects are superior to the detection effects obtained by adopting other primers or probes.
    Type: Grant
    Filed: December 26, 2017
    Date of Patent: August 8, 2023
    Assignee: CREATIVE BIOSCIENCES (GUANGZHOU) CO., LTD.
    Inventors: Xianglin Liu, Hongzhi Zou
  • Patent number: 11713477
    Abstract: The presently disclosed subject matter provides a process for starch liquefaction using at least two classes of ?-amylase enzymes, wherein the starch hydrolysis pattern from at least two of these classes is different. At least one class of enzyme is provided to the liquefaction process in the form of transgenic plant material expressing at least one class of ?-amylase enzyme or is provided in the form of a purified or partially-purified ?-amylase enzyme preparation. The second or subsequent class(es) of ?-amylase enzymes may be provided in the form of additional transgenic plant material expressing the second or subsequent class(es), or may be provided in the form of a second or subsequent purified or partially-purified ?-amylase enzyme preparation.
    Type: Grant
    Filed: August 24, 2021
    Date of Patent: August 1, 2023
    Assignee: Syngenta Participations AG
    Inventor: George W. Aux
  • Patent number: 11713478
    Abstract: The present disclosure relates to methods for characterizing and diagnosing dental diseases. In particular, the present disclosure relates to methods for characterizing and diagnosing dental disease (e.g., gingivitis and periodontal disease) based on levels of AI-2 in oral fluids and plaque.
    Type: Grant
    Filed: August 31, 2020
    Date of Patent: August 1, 2023
    Assignees: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, COLGATE-PALMOLIVE COMPANY
    Inventors: Alexander Rickard, William Giannobile, Michelle Swetky, Nielson T. Baxter, Steven E. Miller, Laurence Du-Thumm, Hans Stettler
  • Patent number: 11678667
    Abstract: The present disclosure provides non-intergeneric remodeled microbes that are able to fix atmostpheric nitrogen and deliver such to plants in a targeted, efficient, and environmentally sustainable manner. The utilization of the taught microbial products will enable farmers to realize more productive and predictable crop yields without the nutrient degradation, leaching, or toxic runoff associated with traditional synthetically derived nitrogen fertilizer. The remodeled microbes taught herein are able to be combined with leading agricultural chemistry and elite germplasm. Furthermore, the disclosure provides seed treatments comprising remodeled microbes.
    Type: Grant
    Filed: January 14, 2022
    Date of Patent: June 20, 2023
    Assignee: PIVOT BIO, INC.
    Inventors: Mark Reisinger, Ernest Sanders, Richard Broglie, Karsten Temme
  • Patent number: 11674874
    Abstract: A vacuum manifold for filtration microscopy includes a manifold top having multiple openings, and a capture membrane positioned above and spaced apart from the manifold top, where the capture membrane is configured to deflect into contact with a surface of the manifold top when a negative pressure is applied to the multiple openings. A method for filtration microscopy includes the steps of providing a vacuum manifold including a manifold top having a plurality of openings, and a capture membrane positioned above and spaced apart from the manifold top; applying sample drops to sample spots on the membrane, the sample spots positioned above the plurality of openings; applying a negative pressure to the openings such that the capture membrane contacts a surface of the manifold top; and optically imaging particulates on the capture membrane.
    Type: Grant
    Filed: June 17, 2022
    Date of Patent: June 13, 2023
    Assignee: Optofluidics Inc.
    Inventors: Thomas Castner, Robert Hart, Colby Ashcroft, Brian DiPaolo, Nathan Wall
  • Patent number: 11667884
    Abstract: The present disclosure provides improved methods for bead beating and a bead beating system useful therefor. The present disclosure further provides methods of using the bead beating system to extract nucleic acids from cells containing the nucleic acids.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: June 6, 2023
    Assignee: Safeguard Biosystems Holdings Ltd.
    Inventors: Holger Klapproth, Nicolaas Smit
  • Patent number: 11642673
    Abstract: A flow cell having at least one storage zone connected to a duct for conducting fluid out of, into or/and through the storage zone. The duct includes a duct section which is delimited by a substrate and a film joined to the substrate and in which the duct is sealed and can be opened at a predetermined breaking point by deflecting the film. The film covers a recess in the substrate which forms the duct section. A sealing wall that seals the duct and is integrally joined to the substrate is placed in the recess. The predetermined breaking point is formed by a breakable joining region between the film and an edge portion of the sealing wall facing the film. The dimensions of a peripheral area of the sealing wall which is formed in the edge portion and runs parallel to the film determine the surface area of the joining region.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: May 9, 2023
    Assignee: THINXXS MICROTECHNOLOGY GMBH
    Inventor: Lutz Weber
  • Patent number: 11634760
    Abstract: The present invention relates to a method for detecting a target nucleic acid, which induces any surrogate target to be amplified in the presence of the target nucleic acid and is useful for molecular diagnosis, prenatal diagnosis, early diagnosis, cancer diagnosis, genetic related diagnosis, genetic trait diagnosis, diagnosis of infectious bacteria, identification of drug-resistant bacteria, forensic medicine, species identification of organisms, and the like.
    Type: Grant
    Filed: November 28, 2018
    Date of Patent: April 25, 2023
    Assignee: PANAGENE INC.
    Inventors: Jaejin Park, Minseo Kim
  • Patent number: 11618895
    Abstract: The present invention relates to a method for extracting nucleic acids from a biological sample, and the extraction method presents a novel method for effectively extracting nucleic acids. When nucleic acids are extracted from biological samples in the related art, various impurities present in the biological samples are not properly removed, such that the purification rate is low, but the present invention provides a method for extracting nucleic acids from a biological sample of which the bacteria, virus and nucleic acid recovery rates are enhanced, by adding a surfactant and a sodium sulfate (Na2SO4) solution in a biological sample disruption step and a purification step, thereby enabling pathogens to be detected more sensitively and accurately.
    Type: Grant
    Filed: August 24, 2018
    Date of Patent: April 4, 2023
    Assignee: CT BIO CO., LTD
    Inventors: Jun Hong Min, Chang Yoon Baek